Anticancer effects of myricetin derivatives in non‐small cell lung cancer in vitro and in vivo
Abstract Lung cancer is the most common cause of cancer‐related deaths. Moreover, exploring efficient tumor‐killing drugs is urgently needed. In our study, several derivative compounds of myricetin were synthesized and tested. Experiments on non‐small cell lung cancer (NSCLC) showed that S4‐2‐2 (5,7...
Saved in:
Main Authors: | Mengmeng Li (Author), Genlan Zha (Author), Rujun Chen (Author), Xin Chen (Author), Qian Sun (Author), Hao Jiang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ultra-small micelles based on polyoxyl 15 hydroxystearate for ocular delivery of myricetin: optimization, in vitro, and in vivo evaluation
by: Yuzhen Hou, et al.
Published: (2019) -
A novel colchicine-myricetin heterozygous molecule: design, synthesis, and effective evaluations on the pathological models of acute lung injury in vitro and in vivo
by: Zhiyue Li, et al.
Published: (2023) -
Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro
by: Xing Chen, et al.
Published: (2018) -
Inhibitory Effect of Kurarinone on Growth of Human Non-small Cell Lung Cancer: An Experimental Study Both in Vitro and in Vivo Studies
by: Jie Yang, et al.
Published: (2018) -
Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo
by: Chen S, et al.
Published: (2019)